{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T21:36:49Z","timestamp":1782337009755,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,9,28]],"date-time":"2005-09-28T00:00:00Z","timestamp":1127865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s00296-005-0031-1","type":"journal-article","created":{"date-parts":[[2005,9,27]],"date-time":"2005-09-27T07:48:28Z","timestamp":1127807308000},"page":"409-415","source":"Crossref","is-referenced-by-count":23,"title":["Pilot clinical study of Adacolumn cytapheresis in patients with systemic lupus erythematosus"],"prefix":"10.1007","volume":"26","author":[{"given":"Helmut","family":"Soerensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana-Maria","family":"Schneidewind-Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhito","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marita","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Ramlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,9,28]]},"reference":[{"key":"31_CR1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM200108023450506","volume":"345","author":"A Davidson","year":"2001","unstructured":"Davidson A, Diamond B (2001) Autoimmune diseases. N Engl J Med 345:340\u2013345","journal-title":"N Engl J Med"},{"key":"31_CR2","first-page":"661","volume":"27","author":"G Sturfelt","year":"2000","unstructured":"Sturfelt G, Bengstsson A, Klint C, Nived O, Sj\u00f6holm A, Truedsson L (2000) Novel roles of complement in systemic lupus erythematosus-hypothesis for a pathogenetic vicious circle. J Rheumatol 27:661\u2013663","journal-title":"J Rheumatol"},{"key":"31_CR3","first-page":"430","volume":"73","author":"O Dar","year":"1988","unstructured":"Dar O, Salaman MR, Seifert MH, Isenberg DA (1988) B-lymphocyte activation in systemic lupus erythematosus: spontaneous production of IgG antibodies to DNA and environmental antigens in cultures of blood mononuclear cells. Clin Exp Immunol 73:430\u2013435","journal-title":"Clin Exp Immunol"},{"key":"31_CR4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1191\/0961203304lu1014oa","volume":"13","author":"T D\u00f6rner","year":"2004","unstructured":"D\u00f6rner T, Lipsky PE (2004) Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosus. Lupus 13:283\u2013289","journal-title":"Lupus"},{"key":"31_CR5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000066857","volume":"6","author":"IU Khan","year":"2003","unstructured":"Khan IU, Tsokos GC, Kammer GM (2003) Abnormal B-cell signal transduction in systemic lupus erythematosus. Curr Dir Autoimmun 6:89\u2013104","journal-title":"Curr Dir Autoimmun"},{"key":"31_CR6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4049\/jimmunol.128.1.258","volume":"128","author":"S Kumagai","year":"1982","unstructured":"Kumagai S, Sredni B, House S, Steinberg AD, Green I (1982) Defective regulation of B-lymphocyte colony formation in patients with systemic lupus erythematosus. J Immunol 128:258\u2013262","journal-title":"J Immunol"},{"key":"31_CR7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/1529-0131(199804)41:4<613::AID-ART8>3.0.CO;2-A","volume":"41","author":"CH Nielsen","year":"1998","unstructured":"Nielsen CH, Rasmussen JM, Voss A, Junker P, Leslie RG (1998) Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes. Arthritis Rheum 41:613\u2013622","journal-title":"Arthritis Rheum"},{"key":"31_CR8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1191\/0961203302lu243oa","volume":"11","author":"H Badsha","year":"2002","unstructured":"Badsha H, Kong KO, Lian TY, Chan SP, Edwards CJ, Chng HH (2002) Low-dose pulse methylprednisolone for systemic lupus erythematosus flares is efficacious and has a decreased risk of infectious complications. Lupus 11:508\u2013513","journal-title":"Lupus"},{"key":"31_CR9","first-page":"1259","volume":"22","author":"M Abu-Shakra","year":"1995","unstructured":"Abu-Shakra M, Urowitz MB, Gladman DD, Gough J (1995) Mortality studies in systemic lupus erythematosus. Results from a single center. I. causes of death. J Rheumatol 22:1259\u20131264","journal-title":"J Rheumatol"},{"key":"31_CR10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/096120339700600307","volume":"6","author":"F Martin","year":"1997","unstructured":"Martin F, Lauwerys B, Lefebvre C, Devogelaer JP, Houssiau FA (1997) Side-effects of intravenous cyclophosphamide pulse therapy. Lupus 6:254\u2013257","journal-title":"Lupus"},{"key":"31_CR11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/art.1780240901","volume":"24","author":"JV Jones","year":"1981","unstructured":"Jones JV, Robinson MF, Parciany RK, Layfer LF, McLeod B (1981) Therapeutic plasmapheresis in systemic lupus erythematosus. Effect on immune complexes and antibodies to DNA. Arthritis Rheum 24:1113\u20131120","journal-title":"Arthritis Rheum"},{"key":"31_CR12","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJM199205213262101","volume":"326","author":"EJ Lewis","year":"1992","unstructured":"Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM (1992) A controlled trial of plasmapheresis therapy in severe lupus nephritis. The lupus nephritis collaborative study group. N Engl J Med 326:1373\u20131379","journal-title":"N Engl J Med"},{"key":"31_CR13","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/art.20430","volume":"50","author":"RJ Looney","year":"2004","unstructured":"Looney RJ, Anolik JH, Campbell D, Felgar RE, Young F, Arend LJ, Sloand JA, Rosenblatt J, Sanz I (2004) B-cell depletion as a novel treatment for systemic lupus erythematosus. Arthritis Rheum 50:2580\u20132589","journal-title":"Arthritis Rheum"},{"key":"31_CR14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/art.10856","volume":"48","author":"DT Boumpas","year":"2003","unstructured":"Boumpas DT, Furie R, Manzi S, Illei GG, Wallace DJ, Balow JE, Vaishnaw A (2003) BG9588 Lupus nephritis trial group. A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis. Arthritis Rheum 48:719\u2013727","journal-title":"Arthritis Rheum"},{"issue":"3","key":"31_CR15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1046\/j.1526-0968.2003.00049.x","volume":"7","author":"K Hiraish","year":"2003","unstructured":"Hiraish K, Takeda Y, Shiobara N, Shibusawa H, Jimma F, Kahiwagi N, Saniabadi AR, Adachi M (2003) Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in\u00a0vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis. Ther Apher Dial 7(3):334\u2013340","journal-title":"Ther Apher Dial"},{"key":"31_CR16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1744-9987.1998.tb00091.x","volume":"2","author":"N Kashiwagi","year":"1998","unstructured":"Kashiwagi N, Hirata I, Kasukawa R (1998) A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis. Ther Apher 2:134\u2013141","journal-title":"Ther Apher"},{"key":"31_CR17","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1023\/A:1015330816364","volume":"47","author":"N Kashiwagi","year":"2002","unstructured":"Kashiwagi N, Sugimura K, Koiwai H, Yamamoto H, Yoshikawa T, Saniabadi AR, Adachi M, Shimoyama T (2002) Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 47:1334\u20131341","journal-title":"Dig Dis Sci"},{"key":"31_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.1000","volume":"16","author":"T Shimoyama","year":"2001","unstructured":"Shimoyama T, Sawada K, Hiwatashi N, Sawada T, Matsueda K, Munakata A, Asakura H, Tanaka T, Kasukawa R, Kimura K, Suzuki Y, Nagamachi Y, Muto T, Nagawa H, Iizuka B, Baba S, Nasu M, Kataoka T, Kashiwagi N, Saniabadi AR (2001) Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher 16:1\u20139","journal-title":"J Clin Apher"},{"key":"31_CR19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1067\/mjd.2002.120597","volume":"47","author":"T Kanekura","year":"2002","unstructured":"Kanekura T, Maruyama I, Kanzaki (2002) Granulocyte and monocyte adsorption apheresis for pyoderma gangrenosum. J Am Acad Dermatol 47:320\u2013321","journal-title":"J Am Acad Dermatol"},{"key":"31_CR20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1526-0968.2003.00012.x","volume":"7","author":"AR Saniabadi","year":"2003","unstructured":"Saniabadi AR, Hanai H, Takeuchi K, Umemura K, Nakashima M, Adachi T, Shima C, Bjarnason I, Lofberg R (2003) Adocolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial 7:48\u201359","journal-title":"Ther Apher Dial"},{"key":"31_CR21","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"31_CR22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Deviation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35:630\u2013638","journal-title":"Arthritis Rheum"},{"key":"31_CR23","first-page":"703","volume":"25","author":"H Uesugi","year":"1998","unstructured":"Uesugi H, Ozaki S, Sobajima J, Osakada F, Shirakawa H, Yoshida M, Nakao K (1998) Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases. J Rheumatol 25:703\u2013709","journal-title":"J Rheumatol"},{"key":"31_CR24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/03009749209099226","volume":"21","author":"Y Hashimoto","year":"1992","unstructured":"Hashimoto Y, Nakano K, Yoshinoya S, Tanimoto K, Itoh K (1992) Endothelial cell destruction by polymorphonuclear leukocytes incubated with sera from patients with systemic lupus erythematosus. Scan J Rheumatol 21:209\u2013214","journal-title":"Scan J Rheumatol"},{"key":"31_CR25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1016523914161","volume":"26","author":"N Kashiwagi","year":"2002","unstructured":"Kashiwagi N, Nakano M, Saniabadi AR, Adachi M, Yoshikawa T (2002) Anti-inflammatory effect of granulocyte and monocyte adsorption apheresis in a rabbit model of immune arthritis. Inflammation 26:199\u2013205","journal-title":"Inflammation"},{"key":"31_CR26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000075053","volume":"208","author":"T Kanekura","year":"2004","unstructured":"Kanekura T, Hashiguchi T, Mera Y, Katahira A, Nakamura I, Maruyama I, Kanzaki T (2004) Improvement of SLE skin rash with granulocyte and monocyte adsorption apheresis. Dermatology 208:79\u201380","journal-title":"Dermatology"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-005-0031-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-005-0031-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-005-0031-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T19:34:27Z","timestamp":1683228867000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-005-0031-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,28]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["31"],"URL":"https:\/\/doi.org\/10.1007\/s00296-005-0031-1","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,28]]}}}